diff --git a/pages/STOP2030___Web___Update 2024___02.md b/pages/STOP2030___Web___Update 2024___02.md
index c6e4983d..9663c600 100644
--- a/pages/STOP2030___Web___Update 2024___02.md	
+++ b/pages/STOP2030___Web___Update 2024___02.md	
@@ -87,4 +87,7 @@
 			- Especificar que la novel formulation es una fixed-dose coformulation de [[Ivermectina]] y [[Albendazol]].
 			- Especificar que esta fixed-dose coformulation de ivm/alb has the lowest [[level]] of investment risk of all candidates for Combinations for [[STH]] treatment (fuente: Soil Transmitted Helminths Drug Combinations Expert Meeting, 2016, Gates Foundation)
 			- Una referencia explícita al Estudio ALIVE: https://gatesopenresearch.org/articles/6-62/v1
+			- Los achievements de los STOP previos
+				- Qualification at EMA for [[article]] 58 (ahora se llama Meds4All, creo)
+				- Proved safety
 			-
\ No newline at end of file